Clinical Trials
26 trialsComparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer
Minia University
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Guangxi Medical University
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PEACE
Azienda Unita Sanitaria Locale di Piacenza
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Peking Union Medical College Hospital
CAP with NAT
Seoul National University Hospital
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
Sun Yat-sen University
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
Sixth Affiliated Hospital, Sun Yat-sen University
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Survival Analysis: TACE vs. Combination Therapy in HCC
Zhejiang University
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Seoul National University Hospital
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Chinese Academy of Sciences
I-ONARC
Niguarda Hospital
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Sun Yat-sen University
"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".
Hospital San Carlos, Madrid
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
LiBReCa
Ente Ospedaliero Cantonale, Bellinzona
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Sohag University
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Peking University Cancer Hospital & Institute
Factors Predicting Recurrence in Rectal Cancer After Surgery
Université de Sousse
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
MMP-7
Region Skane